{"id":813708,"date":"2025-02-17T08:34:46","date_gmt":"2025-02-17T13:34:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/"},"modified":"2025-02-17T08:34:46","modified_gmt":"2025-02-17T13:34:46","slug":"shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/","title":{"rendered":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PHILADELPHIA, Feb.  17, 2025  (GLOBE NEWSWIRE) &#8212; <\/p>\n<p align=\"left\">Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (\u201cInspire Medical\u201d) on behalf of the company\u2019s long-term shareholders.<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <em>Click here for additional information: <\/em><br \/>\n        <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ARYnpi7i-IZuxKGbNDP7K4-eZBABZdf_fqiZV3tgc4Te9OKDb-wJQvGhv17fPQl84VzktaEmu63LnfC58BvKyPTJ35X01jS3oR1_U-dsVTjL9q0PxZ0ZiVNFpRbf1hXD4VYFIVokDUHTfVedLwj6a0Dh7ue--58_Bjf9FmQNecrirblYWDMo9lxJeUH2k_Ji\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>https:\/\/kaskelalaw.com\/cases\/inspire-medical-systems\/<\/em><br \/>\n          <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">Recently a securities fraud complaint was filed against Inspire Medical on behalf of certain investors who purchased shares of the company\u2019s stock between May 3, 2023 and November 7, 2023. According to the complaint, during that time period Inspire Medical and certain of the company\u2019s senior executives made a series of materially false and\/or misleading statements about the company\u2019s \u201cAcceleration Program,\u201d which was reportedly designed to facilitate customers\u2019 receiving prior authorizations from doctors for Inspire Medical\u2019s sleep apnea products (\u201cInspire therapy\u201d) by acting as a liaison between patients and their doctors.<\/p>\n<p align=\"left\">As detailed in the complaint, on November 7, 2023, Inspire Medical announced disappointing earnings results for the third quarter of 2023 \u2013 its first reported revenue miss since becoming a public company in 2018. Therein, the company disclosed that it had started to \u201ctrack\u201d problems with the Acceleration Program in the <em><u>second<\/u><\/em> quarter of 2023, including a decrease in the number of prior authorization submissions for Inspire therapy, and \u201crecogniz[ed] this trend early in the third quarter\u201d (<em>i.e.<\/em>, as early as July 1, 2023).<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <em>Following this news, shares of Inspire Medical\u2019s stock fell $31.79 per share, or nearly 20% in value, from a closing price of $161.74 per share on November 7, 2023 to a closing price of $129.65 per share on November 8, 2023.<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"left\">The investigation seeks to determine whether the members of Inspire Medical\u2019s board of directors violated the securities laws and\/or breached their fiduciary duties in connection with the above alleged misconduct.<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <em>Inspire Medical shareholders who purchased or acquired their currently held INSP shares <\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em><br \/>\n            <u>prior to May 3, 2023<\/u><br \/>\n          <\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em> are encouraged to contact Kaskela Law LLC shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 \u2013 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ARYnpi7i-IZuxKGbNDP7K4-eZBABZdf_fqiZV3tgc4Te9OKDb-wJQvGhv17fPQl84VzktaEmu63LnfC58BvKyDgKAsbqXj_MhC6jr69l7fc5c13xWDsRaiu0IYvrYqfega5QsfNTXOgKmcRjL_xp2KKYN47OsABIqnbU-nLNwjmSCZRNqOqkaAoYBvhFP-q-\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>https:\/\/kaskelalaw.com\/cases\/inspire-medical-systems\/<\/em><br \/>\n          <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RNhG7I2EEY45LcLpuLfU5l0KLzVIIttkGh-nRi9lrQx9Okbh58HXxXAEikbz71YhsFPvCk_WaUD5AI1XEjPPg6wk-J-CZn9WxnREK9YMq-0=\" rel=\"nofollow\" target=\"_blank\">www.kaskelalaw.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>KASKELA LAW LLC<\/strong><br \/>\n        <br \/>D. Seamus Kaskela, Esq.<br \/>(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W6TjCC2y28GyOhgjzJWitjdQ_DL_3VlQ0w_QIra0OKFn0FpO5w-VZLakjJDkTRhQouc9JIo9ZeOtXg6XJ8y2VgwzoVMZTTZoVymaih6Nk44=\" rel=\"nofollow\" target=\"_blank\">skaskela@kaskelalaw.com<\/a>)<br \/>Adrienne Bell, Esq.<br \/>(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H-z8NZKW3PToiv77nmu-rv3fxIXJqoxdP3_kFFlTwEOeKo94cGVtK3tiFbOEDxcPGHgQxYlvNwZ4fGEnEm6CrDYSyVA19eBKAsZdjiJp8Bk=\" rel=\"nofollow\" target=\"_blank\">abell@kaskelalaw.com<\/a>)<br \/>18 Campus Blvd., Suite 100<br \/>Newtown Square, PA 19073<br \/>(888) 715 \u2013 1740<br \/>(484) 229 \u2013 0750<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RNhG7I2EEY45LcLpuLfU5vhOn7UsiB8HkedV0ydG8s_i5RU2Ukgu2arwS0HMvD2cXi1z8Zk6xl5V2IzKplkFaBI2sBqWnpcGhdJsMFejaGQ=\" rel=\"nofollow\" target=\"_blank\">www.kaskelalaw.com<\/a><\/p>\n<p align=\"left\">This notice may constitute attorney advertising in certain jurisdictions.\u00a0\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWEzZTkyYjktNzdlMC00YmQ5LWExZTAtZTMyZmQ0YzJjMDM4LTExMTE1MDY=\/tiny\/Kaskela-Law.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (\u201cInspire Medical\u201d) on behalf of the company\u2019s long-term shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/inspire-medical-systems\/ Recently a securities fraud complaint was filed against Inspire Medical on behalf of certain investors who purchased shares of the company\u2019s stock between May 3, 2023 and November 7, 2023. According to the complaint, during that time period Inspire Medical and certain of the company\u2019s senior executives made a series of materially false and\/or misleading statements about the company\u2019s \u201cAcceleration Program,\u201d which was reportedly designed to facilitate customers\u2019 receiving prior authorizations from doctors for Inspire Medical\u2019s sleep apnea products (\u201cInspire therapy\u201d) by acting as &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-813708","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (\u201cInspire Medical\u201d) on behalf of the company\u2019s long-term shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/inspire-medical-systems\/ Recently a securities fraud complaint was filed against Inspire Medical on behalf of certain investors who purchased shares of the company\u2019s stock between May 3, 2023 and November 7, 2023. According to the complaint, during that time period Inspire Medical and certain of the company\u2019s senior executives made a series of materially false and\/or misleading statements about the company\u2019s \u201cAcceleration Program,\u201d which was reportedly designed to facilitate customers\u2019 receiving prior authorizations from doctors for Inspire Medical\u2019s sleep apnea products (\u201cInspire therapy\u201d) by acting as &hellip; Continue reading &quot;SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-17T13:34:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm\",\"datePublished\":\"2025-02-17T13:34:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/\"},\"wordCount\":449,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/\",\"name\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=\",\"datePublished\":\"2025-02-17T13:34:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm - Market Newsdesk","og_description":"PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (\u201cInspire Medical\u201d) on behalf of the company\u2019s long-term shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/inspire-medical-systems\/ Recently a securities fraud complaint was filed against Inspire Medical on behalf of certain investors who purchased shares of the company\u2019s stock between May 3, 2023 and November 7, 2023. According to the complaint, during that time period Inspire Medical and certain of the company\u2019s senior executives made a series of materially false and\/or misleading statements about the company\u2019s \u201cAcceleration Program,\u201d which was reportedly designed to facilitate customers\u2019 receiving prior authorizations from doctors for Inspire Medical\u2019s sleep apnea products (\u201cInspire therapy\u201d) by acting as &hellip; Continue reading \"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-17T13:34:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm","datePublished":"2025-02-17T13:34:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/"},"wordCount":449,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/","name":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=","datePublished":"2025-02-17T13:34:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxMSM2NzUzNTY2IzIwOTk5MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-inspire-medical-systems-inc-nyse-insp-and-encourages-long-term-inspire-investors-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=813708"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813708\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=813708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=813708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=813708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}